Production (Stage)
The Beauty Health Company
SKIN
$1.61
-$0.12-6.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 322.47M | 334.29M | 347.62M | 366.23M | 393.12M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 322.47M | 334.29M | 347.62M | 366.23M | 393.12M |
Cost of Revenue | 139.96M | 152.00M | 171.98M | 243.80M | 243.75M |
Gross Profit | 182.52M | 182.30M | 175.64M | 122.43M | 149.37M |
SG&A Expenses | 240.83M | 243.77M | 246.49M | 253.15M | 269.40M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 385.28M | 402.07M | 426.60M | 505.79M | 523.71M |
Operating Income | -62.81M | -67.77M | -78.98M | -139.56M | -130.60M |
Income Before Tax | -37.42M | -29.55M | -26.63M | -80.63M | -79.31M |
Income Tax Expenses | 1.10M | -452.00K | 1.54M | 3.07M | 1.23M |
Earnings from Continuing Operations | -38.52 | -29.10 | -28.17 | -83.70 | -80.54 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -38.52M | -29.10M | -28.17M | -83.70M | -80.54M |
EBIT | -62.81M | -67.77M | -78.98M | -139.56M | -130.60M |
EBITDA | -31.61M | -34.09M | -41.88M | -104.04M | -93.53M |
EPS Basic | -0.31 | -0.23 | -0.22 | -0.63 | -0.61 |
Normalized Basic EPS | -0.28 | -0.32 | -0.30 | -0.57 | -0.48 |
EPS Diluted | -0.42 | -0.43 | -0.42 | -0.83 | -0.71 |
Normalized Diluted EPS | -0.26 | -0.29 | -0.28 | -0.55 | -0.47 |
Average Basic Shares Outstanding | 497.26M | 495.30M | 499.61M | 508.45M | 517.45M |
Average Diluted Shares Outstanding | 515.47M | 534.86M | 539.18M | 548.02M | 538.81M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |